We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$60.9B
AUM Growth
-$821M
(-1.3%)
Cap. Flow
-$3.18B
Cap. Flow
% of AUM
-5.23%
Top 10 Holdings %
Top 10 Hldgs %
24.34%
Holding
1,619
New
432
Increased
351
Reduced
430
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$487M |
| 2 |
Kimberly-Clark
KMB
|
+$223M |
| 3 |
Norfolk Southern
NSC
|
+$217M |
| 4 |
Boeing
BA
|
+$167M |
| 5 |
Caterpillar
CAT
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YPF
YPF
|
+$362M |
| 2 |
ICICI Bank
IBN
|
+$270M |
| 3 |
Chevron
CVX
|
+$239M |
| 4 |
AABA
Altaba Inc
AABA
|
+$238M |
| 5 |
Citizens Financial Group
CFG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 15.67% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 13.12% |
| 5 | Communication Services | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$129B
| $63.5M | 0.1% |
1,252,883
-50,597
| -4% | -$2.38M |
|
152
Parker-Hannifin
PH
$120B
| $63.4M | 0.1% |
350,800
-223,920
| -39% | -$38.1M |
|
|
TDF
153
Templeton Dragon Fund
TDF
$269M
| $63.3M | 0.1% |
3,531,755
+63,760
| +2% | +$1.2M |
|
154
Sysco
SYY
$40.8B
| $61.8M | 0.1% |
778,774
+150,267
| +24% | +$11M |
|
155
ZTO Express
ZTO
$18.2B
| $61.4M | 0.1% |
2,879,708
+123,259
| +4% | +$2.48M |
|
156
F5
FFIV
$22B
| $59.9M | 0.1% |
426,815
+157,583
| +59% | +$21.8M |
|
157
UnitedHealth
UNH
$382B
| $59.3M | 0.1% |
272,662
+170,049
| +166% | +$41M |
|
|
WUBA
158
DELISTED
58.com Inc
WUBA
| $59M | 0.1% |
1,196,103
-15,839
| -1% | -$877K |
|
159
AutoZone
AZO
$51.3B
| $58.9M | 0.1% |
54,343
+15,742
| +41% | +$17.6M |
|
160
Shinhan Financial Group
SHG
$32.1B
| $58.4M | 0.1% |
1,667,982
-105,872
| -6% | -$3.76M |
|
161
RTX Corp
RTX
$290B
| $58.2M | 0.1% |
677,419
+21,224
| +3% | +$1.76M |
|
162
CBRE Group
CBRE
$43.3B
| $56M | 0.09% |
1,057,304
+456,649
| +76% | +$24M |
|
163
Amgen
AMGN
$209B
| $56M | 0.09% |
289,211
+115,666
| +67% | +$22.2M |
|
164
Adams Diversified Equity Fund
ADX
$3.01B
| $55.4M | 0.09% |
3,499,654
| – | – |
|
165
McKesson
MCK
$104B
| $53.6M | 0.09% |
392,098
-174,511
| -31% | -$24.8M |
|
166
Henry Schein
HSIC
$9.78B
| $53.3M | 0.09% |
839,504
+651,493
| +347% | +$42.1M |
|
167
NXP Semiconductors
NXPI
$60.8B
| $52.8M | 0.09% |
484,268
-56,688
| -10% | -$5.79M |
|
168
Regions Financial
RF
$26.4B
| $52M | 0.09% |
3,290,188
-39,445
| -1% | -$596K |
|
169
Silicon Motion
SIMO
$7.11B
| $52M | 0.09% |
1,470,648
-254,357
| -15% | -$9.22M |
|
|
IFN
170
Aberdeen India Fund
IFN
$495M
| $51.2M | 0.08% |
2,495,406
+90,675
| +4% | +$1.85M |
|
|
PSB
171
DELISTED
PS Business Parks, Inc.
PSB
| $50.5M | 0.08% |
277,580
-6,905
| -2% | -$1.22M |
|
172
Equinor
EQNR
$97.3B
| $50.2M | 0.08% |
2,646,775
-44,130
| -2% | -$812K |
|
173
Trimble
TRMB
$13.6B
| $49.3M | 0.08% |
1,269,400
-924,107
| -42% | -$37.2M |
|
174
Edison International
EIX
$30.3B
| $48.9M | 0.08% |
648,525
-19,123
| -3% | -$1.38M |
|
|
UN
175
DELISTED
Unilever NV New York Registry Shares
UN
| $47.1M | 0.08% |
785,000
+3,004
| +0.4% | +$180K |
|
Similar funds
QCM
Lazard Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Lazard Asset Management held 1,619 positions worth $60.9B, down 1.3% from $61.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.18B in Q3 2019, closing 152 positions and reducing 430 holdings. Its most notable exit was Altaba Inc, an estimated $238M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Genmab worth $34.3M.
- Lazard Asset Management's largest Q3 2019 buy was Genmab: 1,694,121 shares worth $34.3M.
- Lazard Asset Management added most to CSX Corp in Q3 2019, an estimated $487M increase.
- Lazard Asset Management's biggest Q3 2019 reduction was YPF, cutting an estimated $362M.
- Lazard Asset Management fully exited Altaba Inc in Q3 2019, selling an estimated $238M.
- Lazard Asset Management's ten largest holdings make up 24% of its $60.9B portfolio in Q3 2019.
- Lazard Asset Management opened 432 new positions and closed 152 in Q3 2019.
- Lazard Asset Management's portfolio value fell 1.3% quarter-over-quarter to $60.9B.
Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.